Featured Posts
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Search Posts
Newsletter
Global Warming Allergies, Change at the SEC and Accounting for the Cost of Government
Global warming gets blamed for an increase in allergies. Paul Atkins steps down as Commissioner of the U.S. Securities and Exchange Commission. Taxpayer advocates observe…
Newsletter
Costs of Regulation, FDA Reform and Global Warming Skepticism
The House Small Business Committee hears testimony on the costs of federal regulation. Patient advocates urge lawmakers to pass legislation forcing the Food and Drug…
Citation
Telling McDonald’s it can open franchises only in the white part of town
Newsletter
FCC Takes on Comcast, GM Crops and the Housing Bailout
The Federal Communications Commission puts Comcast in the hot seat over its network management practices. Security becomes the number one cost for scientists developing genetically…
Newsletter
Ethanol’s Sins, Menthol Cigarettes and Property Rights
USA Today details the troubling side effects of using corn-based ethanol as an auto fuel. Legislation to give the Food and Drug Administration authority over…
Newsletter
Environmentalism, Vioxx and Carbon Offsets
The Washington Examiner editorializes on how environmental policies expand the scope of government power. Merck wins two appeals in lawsuits related to its painkiller Vioxx.